HCPLive

Top Medical News Today

Improved Outcomes in Patients with Chronic Hepatitis C Treated with Sofosbuvir Velpatasvir
Treatment with fixed-dos combination sofosbuvir/velpatasvir yielded significant improvements in patient-reported outcomes.
Filgotinib is the first oral, JAK1-selective inhibitor showing efficacy in moderate-to-severe Crohn's disease patients.
Risankizumab is a humanized monoclonal antibody that selectively inhibits IL-23 through specific targeting of the IL-23 p19 subunit.
The chronic vision damaged caused by multiple sclerosis may be reversed by using clemastine fumarate, an over-the-counter drug used to treat allergies and colds.
A study that explored the healthcare burden of chronic infection of the hepatitis C virus found that patients with the disease were more than 3 times likely to be hospitalized than patients in a comparison group.
Retrospective analysis of trial data has found that women with newly diagnosed atrial fibrillation faced an elevated risk of cancer as well.
Patients with psoriatic arthritis experience significant disease-related distress, including suicidal ideation, they are often ill-equipped to cope with.
When addicted physicians seek treatment, they generally succeed. Addiction specialist Joseph Garbely, DO, says physicians usually have too much at stake to fail.
The nation's opioid addiction crisis is not limited to patients. In a Q&A with MD Magazine, addiction specialist Joseph Garbely, DO, says doctors are vulnerable and often wait too long to get help.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$